Literature DB >> 19261635

Degenerative myelopathy in 18 Pembroke Welsh Corgi dogs.

P A March1, J R Coates, R J Abyad, D A Williams, D P O'Brien, N J Olby, J H Keating, M Oglesbee.   

Abstract

Postmortem examination was performed on 18 Pembroke Welsh Corgi dogs (mean age 12.7 years) with clinical signs and antemortem diagnostic tests compatible with a diagnosis of degenerative myelopathy. Tissue sections from specific spinal cord and brain regions were systematically evaluated in all dogs. Axonal degeneration and loss were graded according to severity and subsequently compared across different spinal cord segments and funiculi. White matter lesions were identified in defined regions of the dorsal, lateral, and ventral funiculi. The dorsolateral portion of the lateral funiculus was the most severely affected region in all cord segments. Spinal cord segment T12 exhibited the most severe axonal loss. Spinal nerve roots, peripheral nerves, and brain sections were within normal limits, with the exception of areas of mild astrogliosis in gray matter of the caudal medulla. Dogs with more severe lesions showed significant progression of axonal degeneration and loss at T12 and at cord segments cranial and caudal to T12. Severity of axonal loss in individual dogs positively correlated with the duration of clinical signs. The distribution of axonal degeneration resembled that reported in German Shepherd Dog degenerative myelopathy but differed with respect to the transverse and longitudinal extent of the lesions within more clearly defined funicular areas. Although these lesion differences might reflect disease longevity, they could also indicate a form of degenerative myelopathy unique to the Pembroke Welsh Corgi dog.

Entities:  

Mesh:

Year:  2009        PMID: 19261635     DOI: 10.1354/vp.46-2-241

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  15 in total

1.  The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog.

Authors:  Intan N F Shafie; Mark McLaughlin; Richard Burchmore; Mary Ann A Lim; Paul Montague; Pamela E J Johnston; Jacques Penderis; Thomas J Anderson
Journal:  Cell Stress Chaperones       Date:  2013-08-29       Impact factor: 3.667

2.  Degenerative myelopathy in German Shepherd Dog: comparison of two molecular assays for the identification of the SOD1:c.118G>A mutation.

Authors:  Maria Teresa Capucchio; Veronica Spalenza; Elena Biasibetti; Maria Teresa Bottero; Roberto Rasero; Alessandra Dalmasso; Paola Sacchi
Journal:  Mol Biol Rep       Date:  2014-01-05       Impact factor: 2.316

3.  Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; Alyssa C Bujnak; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-09-16       Impact factor: 4.164

4.  Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis.

Authors:  Tomoyuki Awano; Gary S Johnson; Claire M Wade; Martin L Katz; Gayle C Johnson; Jeremy F Taylor; Michele Perloski; Tara Biagi; Izabella Baranowska; Sam Long; Philip A March; Natasha J Olby; G Diane Shelton; Shahnawaz Khan; Dennis P O'Brien; Kerstin Lindblad-Toh; Joan R Coates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

5.  Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy.

Authors:  Emma L Ivansson; Kate Megquier; Sergey V Kozyrev; Eva Murén; Izabella Baranowska Körberg; Ross Swofford; Michele Koltookian; Noriko Tonomura; Rong Zeng; Ana L Kolicheski; Liz Hansen; Martin L Katz; Gayle C Johnson; Gary S Johnson; Joan R Coates; Kerstin Lindblad-Toh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

6.  Lumbar spinal cord microglia exhibited increased activation in aging dogs compared with young adult dogs.

Authors:  Christine M Toedebusch; Virginia B Garcia; John C Snyder; Maria R Jones; David J Schulz; Gayle C Johnson; Eric Villalón; Joan R Coates; Michael L Garcia
Journal:  Geroscience       Date:  2019-12-11       Impact factor: 7.713

7.  Characterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; G Diane Shelton; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-12-21       Impact factor: 4.164

8.  A retrospective study of the prevalence of the canine degenerative myelopathy associated superoxide dismutase 1 mutation (SOD1:c.118G > A) in a referral population of German Shepherd dogs from the UK.

Authors:  Angela L Holder; James A Price; Jamie P Adams; Holger A Volk; Brian Catchpole
Journal:  Canine Genet Epidemiol       Date:  2014-09-25

9.  Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy.

Authors:  C M Toedebusch; M D Bachrach; V B Garcia; G C Johnson; M L Katz; G Shaw; J R Coates; M L Garcia
Journal:  J Vet Intern Med       Date:  2017-02-10       Impact factor: 3.333

10.  Breed distribution of SOD1 alleles previously associated with canine degenerative myelopathy.

Authors:  R Zeng; J R Coates; G C Johnson; L Hansen; T Awano; A Kolicheski; E Ivansson; M Perloski; K Lindblad-Toh; D P O'Brien; J Guo; M L Katz; G S Johnson
Journal:  J Vet Intern Med       Date:  2014-02-13       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.